IT & Data Management
Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to...
To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry--- bioLIVE China...
IT & Data Management
Patient-Data Platform Raremark Enhances Executive Team to Accelerate Progress...
Raremark, the leading patient-data platform in rare disease, is pleased to announce additions to its executive team to speed the company’s pursuit of more treatments...
Clinical Trials
Eli Lilly and Company in Collaboration with Strateos Launch...
Eli Lilly and Company and Strateos, Inc. unveiled a new robotic laboratory in San Diego, California designed to accelerate the drug discovery process. The Lilly...
Clinical Trials
Moderna Announces Additional Positive Phase 1 Data from CMV...
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced...
Drug Research
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11...
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced the acquisition of worldwide exclusive rights to Enleofen’s preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to...
Drug Research
BI Vaccines Announces Second Pivotal Phase 3 Study of...
VBI Vaccines Inc. (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported top-line data from CONSTANT, the second pivotal Phase 3...
Drug Research
Generation Bio Announces $110 Million Series C Financing to...
Generation Bio, a company leading a new generation of gene therapy, announced the closing of a $110 million Series C financing. Proceeds will be used...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.